ESPAD Logo

Italy

Databases

Key results 2015

For one of the eight key variables, namely lifetime use of inhalants (3 % compared to 7 %), the Italian students reported prevalence rates below the ESPAD average. Lifetime use of illicit drugs other than cannabis, lifetime use of tranquillisers or sedatives without prescription and lifetime use of NPS were more or less of the same magnitude as the overall average. Heavy episodic drinking in the last 30 days was also on the same level as the ESPAD average. On the other hand, higher proportions of the students in Italy reported that they had used alcohol and cigarettes during the last 30 days. Lifetime use of cannabis was also more commonly reported by the Italian students (27 % compared to 16 %). The most obvious differences compared with the average ESPAD country were the higher prevalence rates in Italy for use of cigarettes and cannabis and the lower rates for use of inhalants.

Country facts:
Area: 301300 km2
Population: 60,3 million

Country contacts: 

Sabrina Molinaro 
Principal Investigator

Institute of Clinical Physiology (CNR)
via Moruzzi 1
56100 Pisa
Tel: +39 0503152094

Valeria Siciliano 
Associated Principal Investigator

Institute of Clinical Physiology (CNR)
via Moruzzi 1
56100 Pisa
Tel: +39 0503152094

Loredana Fortunato 
Contact Person

Institute of Clinical Physiology (CNR)
via Moruzzi 1
56100 Pisa
Tel: +39 0503152094